Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209,641 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Semaglutide is effective in type 2 diabetes and obesity with schizophrenia.
Noda K, Kato T, Nomura N, Sakai M, Kubota S, Hirose T, Liu Y, Takahashi Y, Takao K, Mizuno M, Hirota T, Suwa T, Horikawa Y, Yabe D. Noda K, et al. Among authors: liu y. Diabetol Int. 2022 Jun 15;13(4):693-697. doi: 10.1007/s13340-022-00590-1. eCollection 2022 Oct. Diabetol Int. 2022. PMID: 36117924 Free PMC article.
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N. Liu Y, et al. FASEB J. 2019 May;33(5):6239-6253. doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21. FASEB J. 2019. PMID: 30789757
Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.-Liu, Y., Harashima, S., Wang, Y., Suzuki, K., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, …
Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.-Liu, …
Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report.
Takao K, Tani A, Suwa T, Kuwabara-Ohmura Y, Nonomura K, Liu Y, Kato T, Mizuno M, Hirota T, Enya M, Iizuka K, Horikawa Y, Saigo C, Kito Y, Miyazaki T, Ohe N, Iwama T, Yabe D. Takao K, et al. Among authors: liu y. BMC Endocr Disord. 2021 Jan 11;21(1):13. doi: 10.1186/s12902-020-00675-5. BMC Endocr Disord. 2021. PMID: 33430828 Free PMC article.
Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesis.
Takao K, Iizuka K, Liu Y, Sakurai T, Kubota S, Kubota-Okamoto S, Imaizumi T, Takahashi Y, Rakhat Y, Komori S, Hirose T, Nonomura K, Kato T, Mizuno M, Suwa T, Horikawa Y, Sone M, Yabe D. Takao K, et al. Among authors: liu y. J Endocrinol. 2021 Mar;248(3):317-324. doi: 10.1530/JOE-20-0442. J Endocrinol. 2021. PMID: 33538705
A novel RFX6 heterozygous mutation (p.R652X) in maturity-onset diabetes mellitus: A case report.
Imaki S, Iizuka K, Horikawa Y, Yasuda M, Kubota S, Kato T, Liu Y, Takao K, Mizuno M, Hirota T, Suwa T, Hosomichi K, Tajima A, Fujiwara Y, Yamazaki Y, Kuwata H, Seino Y, Yabe D. Imaki S, et al. Among authors: liu y. J Diabetes Investig. 2021 Oct;12(10):1914-1918. doi: 10.1111/jdi.13545. Epub 2021 Apr 9. J Diabetes Investig. 2021. PMID: 33721395 Free PMC article.
Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherence.
Tominari S, Yasuda M, Kato T, Sakai M, Kubota S, Nonomura K, Hirose T, Takao K, Liu Y, Mizuno M, Hirota T, Iizuka K, Suwa T, Horikawa Y, Yabe D. Tominari S, et al. Among authors: liu y. Diabetol Int. 2021 May 5;13(1):295-299. doi: 10.1007/s13340-021-00510-9. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059266 Free PMC article.
209,641 results
You have reached the last available page of results. Please see the User Guide for more information.